HROW
Price
$31.35
Change
-$0.20 (-0.63%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
467.85M
46 days until earnings call
IRWD
Price
$0.77
Change
+$0.02 (+2.67%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
1.36B
41 days until earnings call
Interact to see
Advertisement

HROW vs IRWD

Header iconHROW vs IRWD Comparison
Open Charts HROW vs IRWDBanner chart's image
Harrow
Price$31.35
Change-$0.20 (-0.63%)
Volume$1.53K
Capitalization467.85M
Ironwood Pharmaceuticals
Price$0.77
Change+$0.02 (+2.67%)
Volume$18.89K
Capitalization1.36B
HROW vs IRWD Comparison Chart in %
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. IRWD commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Buy and IRWD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (HROW: $31.35 vs. IRWD: $0.78)
Brand notoriety: HROW and IRWD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HROW: 77% vs. IRWD: 54%
Market capitalization -- HROW: $467.85M vs. IRWD: $1.36B
HROW [@Pharmaceuticals: Other] is valued at $467.85M. IRWD’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileIRWD’s FA Score has 1 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • IRWD’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 3 TA indicator(s) are bullish while IRWD’s TA Score has 6 bullish TA indicator(s).

  • HROW’s TA Score: 3 bullish, 5 bearish.
  • IRWD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IRWD is a better buy in the short-term than HROW.

Price Growth

HROW (@Pharmaceuticals: Other) experienced а -0.54% price change this week, while IRWD (@Pharmaceuticals: Other) price change was +11.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +14.45%, and the average quarterly price growth was +91.39%.

Reported Earning Dates

HROW is expected to report earnings on Aug 12, 2025.

IRWD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRWD($1.36B) has a higher market cap than HROW($468M). HROW has higher P/E ratio than IRWD: HROW (39.53) vs IRWD (10.31). HROW YTD gains are higher at: -6.557 vs. IRWD (-82.433). HROW has higher annual earnings (EBITDA): 9.95M vs. IRWD (-924.84M). IRWD has more cash in the bank: 92.2M vs. HROW (82.8M). HROW has less debt than IRWD: HROW (191M) vs IRWD (716M). IRWD has higher revenues than HROW: IRWD (443M) vs HROW (130M).
HROWIRWDHROW / IRWD
Capitalization468M1.36B34%
EBITDA9.95M-924.84M-1%
Gain YTD-6.557-82.4338%
P/E Ratio39.5310.31383%
Revenue130M443M29%
Total Cash82.8M92.2M90%
Total Debt191M716M27%
FUNDAMENTALS RATINGS
HROW vs IRWD: Fundamental Ratings
HROW
IRWD
OUTLOOK RATING
1..100
188
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4165
P/E GROWTH RATING
1..100
1111
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRWD's Valuation (75) in the Pharmaceuticals Other industry is in the same range as HROW (76). This means that IRWD’s stock grew similarly to HROW’s over the last 12 months.

HROW's Profit vs Risk Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for IRWD (100). This means that HROW’s stock grew somewhat faster than IRWD’s over the last 12 months.

HROW's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that HROW’s stock grew similarly to IRWD’s over the last 12 months.

HROW's Price Growth Rating (41) in the Pharmaceuticals Other industry is in the same range as IRWD (65). This means that HROW’s stock grew similarly to IRWD’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is in the same range as IRWD (11). This means that HROW’s stock grew similarly to IRWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWIRWD
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 14 days ago
81%
Bearish Trend 14 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GBLFX39.390.33
+0.84%
American Funds Global Balanced F2
MSMIX30.540.24
+0.79%
NYLI WMC Value Investor Class
FIRTX10.02N/A
N/A
Fidelity Advisor Intl Real Estate M
NEXTX32.79N/A
N/A
Shelton Sustainable Equity Investor
IDVSX27.68N/A
N/A
Morgan Stanley Inst Intl Advtg R6

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-0.63%
AMRX - HROW
46%
Loosely correlated
+0.99%
EBS - HROW
38%
Loosely correlated
+0.89%
OGI - HROW
34%
Loosely correlated
+2.94%
TLRY - HROW
33%
Loosely correlated
+4.72%
VTRS - HROW
32%
Poorly correlated
+2.59%
More

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+3.90%
ACET - IRWD
30%
Poorly correlated
+1.91%
PRGO - IRWD
29%
Poorly correlated
-0.19%
ASRT - IRWD
26%
Poorly correlated
+3.09%
ELAN - IRWD
24%
Poorly correlated
+3.92%
HROW - IRWD
24%
Poorly correlated
-0.63%
More